SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-109400
Filing Date
2017-04-04
Accepted
2017-04-04 08:11:34
Documents
5
Period of Report
2017-04-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d373630d8k.htm 8-K 15067
2 EX-99.1 d373630dex991.htm EX-99.1 22252
3 EX-99.2 d373630dex992.htm EX-99.2 12993
4 GRAPHIC g373630ex99_1logo.jpg GRAPHIC 707453
5 GRAPHIC g373630g0404100948479.jpg GRAPHIC 2816
  Complete submission text file 0001193125-17-109400.txt   1030177
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 17736219
SIC: 8731 Services-Commercial Physical & Biological Research